Counseling Points - October 2007 - (Page 2)

Faculty: Kathy Byrd, RN, BSN Director of Research Dawes Fretzin Dermatology Group, LLC Indianapolis, Indiana Mary Coughlin, RN, MS Nurse Manager Director of Research Clinical Pharmacology Study Group Worcester, Massachusetts Therese Dexter, RN, BSN SC President, Rheumatology Nurses Society Manager of Infusion Services Arizona Arthritis & Rheumatology Associates Paradise Valley, Arizona Faculty Disclosure Statements: Kathy Byrd has received honoraria for presentations from Abbott Immunology and Centocor. Mary Coughin has received honoraria for participating on a Nursing Advisory Board and in a Nursing Speakers Bureau from Bristol Myers Squibb. Therese Dexter has received honoraria for speaking from Bristol Myers Squibb, Centocor, Genentech, and Tanabe (Japan). She has also received honoraria for participating in a Nursing Advisory Board from Roche. Publishing Information: Publishers Joseph J. D’Onofrio Frank M. Marino David Zied Delaware Media Group 66 South Maple Avenue Ridgewood, NJ 07450 201-612-7676 Fax: 201-612-8282 www.delmedgroup.com Editorial Director Nancy Monson Medical Editor/Writer Kathryn Klobnak Art Director James Ticchio Cover photo credit: ©Alain Pol/ISM/Phototake © 2007, Delaware Media Group, Inc. All rights reserved. None of the contents may be reproduced in any form without prior written permission from the publisher. The opinions expressed in this publication are those of the faculty and do not necessarily reflect the opinions or recommendations of their affiliated institutions, the publisher, the Infusion Nurses Society, or Roche Pharmaceuticals. Counseling Points™ Rheumatoid Arthritis: Epidemiology, Symptomatology, and Natural History of the Disease Process Continuing Education Information Target Audience This educational activity is designed to meet the needs of infusion nurses and nurse practitioners involved directly in early and long-term management of patients with rheumatoid arthritis (RA). Learning Objectives Upon completion of this educational activity, the participant should be able to: • Discuss the prevalence, economic burden, morbidity, and mortality rates associated with rheumatoid arthritis (RA) • Explain the pathophysiology and risk factors for RA • List the symptoms of RA • Describe the natural history of the disease process and its implications for disease management Continuing Education Credit The Infusion Nurses Society (INS) is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. Nurses who practice in states that mandate continuing education for licensure are responsible for validating this education program with his/her state’s licensing board. INS is accredited as a provider of continuing nursing education by the California Board of Registered Nursing, Provider # CEP 14209. Nurses licensed by the California Board of Registered Nursing must retain their CE document for a period of 4 years. This continuing education activity is approved by the Infusion Nurses Certification Corporation (INCC) for 1 recertification unit. This continuing education activity is approved for 1.0 contact hour. This program expires October 31, 2009. Disclosure of Unlabeled Use This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA.The Infusion Nurses Society, Roche Pharmaceuticals, and Delaware Media Group do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the Infusion Nurses Society, Roche Pharmaceuticals, or Delaware Media Group. Disclaimer Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any medications, diagnostic procedures, or treatments discussed in this publication should not be used by clinicians or other health care professionals without first evaluating their patients’ conditions, considering possible contraindications or risks, reviewing any applicable manufacturer’s product information, and comparing any therapeutic approach with the recommendations of other authorities. 2 COUNSELING POINTS™ http://www.delmedgroup.com

Table of Contents Feed for the Digital Edition of Counseling Points - October 2007

Counseling Points - October 2007 Welcome Introduction Overview of RA RA Morbidity and Mortality RA Costs and Quality of Life RA Risk Factors Pathophysiology of RA Diagnosis and Natural History of RA Diagnostic Tests and Radiography Natural History and Progression of RA Disease Management Treatment Strategies Summary Continuing Education Posttest Evaluation Form

Counseling Points - October 2007

For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.